Skip to main content
Figure 4 | EJNMMI Research

Figure 4

From: Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount

Figure 4

Tumour control probability vs tumour mass. TCP versus tumour mass for a single 111 MBq 90Y (A), multiple administrations 4 × 20 MBq 90Y (B), 5 × 359 MBq 111In (C), 6 × 47 MBq 177Lu (D) and 4 × 16.8 MBq 213Bi (E) for tumour doubling times varying between 1 and 28 days, and for the static tumour, as shown in Figure 3. Only bars for TCP > 0.05 are shown, except for 213Bi where the 14- and 18-day doubling time results were almost equal to the static (without tumour growth) TCP shown with the blue bars.

Back to article page